News
A deft uveitis diagnosis can help reveal underlying systemic infections, neoplastic conditions, and other systemic illnesses.
Inflammatory diseases presenting with anterior uveitis and hypopyon may include HLA-B27-associated anterior uveitis or possibly Behçet’s disease, but a secondary keratitis or corneal ulceration ...
Hosted on MSN2mon
Keeping Your Eyes Healthy With Ankylosing Spondylitis - MSNThe eye inflammation known as uveitis occurs in 20 to 30 percent of people with ankylosing spondylitis. It is considered a medical emergency.
2025 MAR 28-- By a News Reporter-Staff News Editor at Information Technology Business Daily-- New research on Eye Diseases and Conditions- Anterior Uveitis is the subject of a report. According to ...
(HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to ...
For individuals with type 2 diabetes, semaglutide is tied to a modestly increased risk for nonarteritic anterior ischemic optic neuropathy.
An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions associated with the inflammation of the eye's iris, also known as anterior uveitis.
High-performance specialist Geoff Scott explains the procedure and why someone might play on ...
KOLOA, Hawaii — Start with the patient’s chief complaint when making a differential diagnosis in uveitis, a retina specialist said at Retina 2025. “You see a new uveitis patient ...
In addition to the inflammatory reaction in the anterior segment, the retina and choroid are also involved in the pathological process (12, 13). The EIU model is widely used in the study of the ...
Uveitis was most common; in multivariable analyses, acute anterior uveitis was directly associated with the presence of human leukocyte antigen (HLA)-B27 and inversely associated with smoking.
(RTTNews) - Shares of ACELYRIN, Inc. (SLRN) are down over 17% in premarket trading, following disappointing results from its Phase 2b/3 trial of Izokibep in non-infectious, non-anterior uveitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results